跳至主要内容
临床试验/NCT02686021
NCT02686021已完成4 期

Potential Benefit of the Combination of Metamizole and Ibuprofen After Third Lower Molar Extraction

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2016年2月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
36
试验地点
1
主要终点
area under the curve for pain in the first 12 postoperative hours

研究概览

简要总结

Postoperative pain is common and particularly outpatients may experience unsatisfactory pain relief. This randomized, double-blind, crossover study of postoperative pain in outpatients undergoing split-mouth, third lower molar extraction aims to examine whether or not the combination of metamizole and ibuprofen is superior to either drug alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • planned sequential both-sided lower third molar extraction (split-mouth) with osteotomy (with or without upper molar extraction in local anesthesia)
  • able to understand the study and the NRS scale

排除标准

  • simultaneous both sided extraction or only upper third molar extraction
  • general anesthesia
  • known or presumed abnormal coagulation status
  • known or presumed liver or renal dysfunction
  • contraindication against metamizole known or suspected (known or suspected allergy against novalgin or other pyrazolones, anaphylactic reaction against NSAIDS, decreased bone marrow function or hematopoesis, hepatic porphyria, glucose-6-phosphate dehydrogenase deficiency, and pregnancy/breastfeeding)
  • contraindication against ibuprofen (known or suspected allergy against ibuprofen, anaphylactic reaction against Nonsteroidal anti-inflammatory drugs (NSAID), active or recurrent stomach or duodenal ulcera or bleeding, severe liver or renal insufficiency, inflammatory bowel syndrome, and pregnancy/breastfeeding)
  • pregnancy and breast feeding mothers

研究组 & 干预措施

Metamizole and Ibuprofen

Experimental

all patients (n=42) will receive metamizol and ibuprofen in one session. In the other session half will receive metamizol and placebo (n=21) and the other half will receive ibuprofen and placebo. The order will be randomized (balanced).

干预措施: Metamizole and Ibuprofen (Drug)

Metamizole and Placebo

Active Comparator

This is one of the two comparators for the Arm "Metamizol and Ibuprofen". n=21

干预措施: Metamizole and Placebo (Drug)

Ibuprofen and Placebo

Active Comparator

This is the second of the two comparators for the Arm "Metamizol and Ibuprofen". n=21

干预措施: Ibuprofen and Placebo (Drug)

结局指标

主要结局

area under the curve for pain in the first 12 postoperative hours

时间窗: first 12 postoperative hours

The primary outcome is the area under the curve for pain in the first 12 postoperative hours, as assessed by the numeric rating scale

次要结局

  • area under the curve for pain in the first 18 postoperative hours(first 18 postoperative hours)
  • night time pain(first night after the intervention)
  • highest pain score(total observation period (maximum 18 hours))
  • haemorrhage requiring intervention(total observation period (maximum 18 hours))
  • need for and timing of rescue medication(total observation period (maximum 18 hours))

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验